TY  - JOUR
T1  - Comparative efficacy of newer antioxidants spirulina and lycopene for the treatment of oral submucous fibrosis
A1  - Santosh Patil
A1  - Suneet Khandelwal
A1  - Sneha Maheshwari
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2014
VL  - 3
IS  - 6
DO  - 10.4103/2278-0513.142618
SP  - 482
EP  - 486
N2  - Context: Oral submucous fibrosis (OSMF) is a high-risk premalignant condition predominantly seen in the Indian subcontinent. The aim of the present study was to compare the efficacy of spirulina and lycopene in the management of OSMF. Materials and Methods: Sixty-eight subjects with clinico-pathologically diagnosed OSMF were included in the study which was conducted from March, 2013 to July, 2013. They were divided equally in two groups, Group A (spirulina group) and Group B (lycopene group). Group A was administered 500 mg spirulina in two divided doses for 3 months, and Group B was given 8 mg lycopene in two divided doses of 4 mg for 3 months. Evaluation for different clinical parameters was done at regular intervals and data was analyzed using the Student′s paired t-test and Chi-square test. P 
UR  - https://ccij-online.org/article/comparative-efficacy-of-newer-antioxidants-spirulina-and-lycopene-for-the-treatment-of-oral-submucous-fibrosis-280
ER  -